Harm Reduction Therp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HARM REDUCTION THERP, and when can generic versions of HARM REDUCTION THERP drugs launch?
HARM REDUCTION THERP has one approved drug.
There are two US patents protecting HARM REDUCTION THERP drugs.
There are forty-five patent family members on HARM REDUCTION THERP drugs in thirty-six countries and one supplementary protection certificate in one country.
Summary for Harm Reduction Therp
International Patents: | 45 |
US Patents: | 2 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Harm Reduction Therp
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harm Reduction Therp | RIVIVE | naloxone hydrochloride | SPRAY, METERED;NASAL | 217722-001 | Jul 28, 2023 | OTC | Yes | Yes | 11,806,428 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Harm Reduction Therp | RIVIVE | naloxone hydrochloride | SPRAY, METERED;NASAL | 217722-001 | Jul 28, 2023 | OTC | Yes | Yes | 11,020,343 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Harm Reduction Therp Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 103764119 | ⤷ Sign Up |
New Zealand | 705933 | ⤷ Sign Up |
New Zealand | 617442 | ⤷ Sign Up |
Turkey | 201802716 | ⤷ Sign Up |
Serbia | 57054 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Harm Reduction Therp Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | 92292 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.